Table 2.
Incidence of RVO in ESRD group, KT group and healthy controls.
| Outcomes | Groups | RVO | Duration | Rate | Model 1 | Model 2 | Model 3 | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Event | Patient-years | Per 1000 patient-years | Hazard ratio (95% CI) | P-value | Hazard ratio (95% CI) | P-value | Hazard ratio (95% CI) | P-value | |||
| RVO, total | ESRD | 290 | 51,047.6 | 5.68 | 5.54 (4.22, 7.23) | < 0.001 | 5.71 (4.35, 7.50) | < 0.001 | 3.21 (2.19, 4.70) | < 0.001 | |
| KT | 164 | 59,847.8 | 2.74 | 2.70 (2.02, 3.60) | < 0.001 | 2.72 (2.03, 3.64) | < 0.001 | 1.53 (1.02, 2.29) | 0.034 | ||
| Healthy | 63 | 62,050.0 | 1.02 | 1 (ref) | 1 (ref) | 1 (ref) | |||||
| Non-ischemic RVO | ESRD | 235 | 51,047.6 | 4.60 | 5.25 (3.90, 7.06) | < 0.001 | 5.49 (4.02, 7.27) | < 0.001 | 3.08 (2.03, 4.69) | < 0.001 | |
| KT | 135 | 59,847.8 | 2.26 | 2.59 (1.89, 3.56) | < 0.001 | 2.61 (1.91, 3.58) | < 0.001 | 1.49 (0.97, 2.30) | 0.069 | ||
| Healthy | 54 | 62,050.0 | 0.87 | 1 (Ref.) | 1 (Ref.) | 1 (Ref.) | |||||
| Ischemic RVO | ESRD | 55 | 51,047.6 | 1.07 | 7.27 (3.60, 14.72) | < 0.001 | 7.53 (3.72, 15.24) | < 0.001 | 3.89 (1.50, 10.06) | 0.005 | |
| KT | 29 | 59,847.8 | 0.48 | 3.33 (1.58, 7.04) | 0.002 | 3.37 (1.59, 7.11) | 0.002 | 1.75 (0.66, 4.66) | 0.263 | ||
| Healthy | 9 | 62,050.0 | 0.15 | 1 (Ref.) | 1 (Ref.) | 1 (Ref.) | |||||
Analysis was performed using Cox regression. Model 1: not adjusted; Model 2: adjusted with age, sex; Model 3: adjusted with age, sex, diabetes mellitus, hypertension, dyslipidemia, Charlson comorbidity index, income status.
CI confidence interval, ESRD end stage renal disease, KT kidney transplantation, RVO renal vein occlusion.